Bayer makes new $2 billion plan to head off future Roundup cancer claims
Monsanto owner Bayer AG said Wednesday it was attempting again to manage and resolve potential future Roundup cancer claims, laying out a $2 billion deal with a group of plaintiffs’ attorneys that Bayer hopes will win approval from a federal judge who rejected a prior plan last summer. Notably, the deal calls for Bayer to … Bayer makes new $2 billion plan to head off future Roundup cancer claims
